The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of generic https://bookmarkpagerank.com/story21449526/sildenafil-and-big-pharma-a-uncertain-opportunity